11
TITLE: Artificial intelligence for prediction of biological activities and generation of molecular hits using stereochemical information
AUTHORS: Pereira, Tiago O.; Abbasi, Maryam; Oliveira, Rita I.; Guedes, Romina A.; Salvador, Jorge A. R.; Arrais, Joel P.;
PUBLISHED: 2023, SOURCE: JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, VOLUME: 37, ISSUE: 12
INDEXED IN: WOS CrossRef: 1
IN MY: ORCID
12
TITLE: Revisiting Proteasome Inhibitors: Molecular Underpinnings of their Development, Mechanisms of Resistance and Strategies to Overcome Anti‐Cancer Drug Resistance
AUTHORS: Carlota Leonardo‐sousa; Andreia Neves Carvalho; Romina A Guedes; Pedro M P Fernandes; Natália Aniceto; Jorge A R Salvador; Maria João Gama; Rita C Guedes;
PUBLISHED: 2022, SOURCE: Molecules, VOLUME: 27, ISSUE: 7
INDEXED IN: Scopus CrossRef: 15
IN MY: ORCID
13
TITLE: Deep generative model for therapeutic targets using transcriptomic disease-associated data-USP7 case study
AUTHORS: Pereira, Tiago; Abbasi, Maryam; Oliveira, Rita, I; Guedes, Romina A.; Salvador, Jorge A. R.; Arrais, Joel P.;
PUBLISHED: 2022, SOURCE: BRIEFINGS IN BIOINFORMATICS, VOLUME: 23, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID
14
TITLE: Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment
AUTHORS: Rita C Acúrcio; Sabina Pozzi; Barbara Carreira; Marta Pojo; Nuria Gómez Cebrián; Sandra Casimiro; Adelaide Fernandes; Andreia Barateiro; Vitor Farricha; Joaquim Brito; Ana Paula Leandro; Jorge A R Salvador; Luís Graça; Leonor Puchades Carrasco; Luís Costa; Ronit Satchi Fainaro; Rita C Guedes; Helena F Florindo;
PUBLISHED: 2022, SOURCE: Journal for immunotherapy of cancer, VOLUME: 10, ISSUE: 7
INDEXED IN: Scopus CrossRef: 23
IN MY: ORCID
15
TITLE: Highlights in USP7 inhibitors for cancer treatment
AUTHORS: Oliveira, Rita I.; Guedes, Romina A.; Salvador, Jorge A. R.;
PUBLISHED: 2022, SOURCE: FRONTIERS IN CHEMISTRY, VOLUME: 10
INDEXED IN: Scopus WOS CrossRef: 18
IN MY: ORCID
16
TITLE: MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment
AUTHORS: Vicente, Andre T. S.; Salvador, Jorge A. R.;
PUBLISHED: 2022, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 23, ISSUE: 19
INDEXED IN: Scopus WOS CrossRef: 17
IN MY: ORCID
17
TITLE: Design, synthesis, and biological evaluation of new arjunolic acid derivatives as anticancer agents
AUTHORS: Gonçalves, BMF; Mendes, VIS; Silvestre, SM; Salvador, JAR;
PUBLISHED: 2022, SOURCE: RSC Medicinal Chemistry, VOLUME: 14, ISSUE: 2
INDEXED IN: Scopus CrossRef: 1
IN MY: ORCID
18
TITLE: Editorial: Head & Neck Cancer and Esophageal Cancer: From Biosignatures to Therapeutics  Full Text
AUTHORS: Kok, VC; Yu, CC; Salvador, JAR;
PUBLISHED: 2021, SOURCE: FRONTIERS IN ONCOLOGY, VOLUME: 11
INDEXED IN: Scopus WOS
19
TITLE: A patent review of glutaminyl cyclase inhibitors (2004-present)
AUTHORS: Coimbra, JRM; Salvador, JAR;
PUBLISHED: 2021, SOURCE: EXPERT OPINION ON THERAPEUTIC PATENTS, VOLUME: 31, ISSUE: 9
INDEXED IN: WOS CrossRef: 8
IN MY: ORCID
20
TITLE: Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors  Full Text
AUTHORS: Coimbra, JRM; Baptista, SJ; Dinis, TCP; Silva, MMC; Moreira, PI; Moreira, Paula Isabel; Paula I. Moreira ; Santos, AE; Salvador, JAR;
PUBLISHED: 2020, SOURCE: BIOMOLECULES, VOLUME: 10, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 13
IN MY: ORCID
Page 2 of 9. Total results: 84.